Matsumoto, Toshihiko
Ikoma, Tatsuki
Makiyama, Chinatsu
Yasuda, Tomoyo
Boku, Shogen
Nakasya, Akio
Shibata, Nobuhiro
Nagai, Hiroki
Tsuduki, Takao
Matsumoto, Yusuke
Yasui, Hisateru
Higashi, Reiji
Sasamoto, Akitoshi
Satake, Hironaga
Inoue, Kentaro
Kanai, Masashi
Yamasaki, Makoto
Article History
Received: 26 May 2025
Accepted: 25 July 2025
First Online: 7 August 2025
Conflict of interests
: Toshihiko Matsumoto received research funding from Ono Pharmaceutical Co, Ltd and Sanofi Co, Ltd; honoraria from Bayer Co, Ltd, Bristol-Myers Squibb Co, Ltd, Chugai Pharmaceutical Co, Ltd, Daiichi Sankyo Co, Ltd, Eli Lilly Japan Co, Ltd, Merck Bio Pharma Co, Ltd, MSD Co, Ltd, Ono Pharmaceutical Co, Ltd, Sanofi Co, Ltd, Taiho Pharmaceutical Co, Ltd, Takeda Co, Ltd, Teijin Pharmaceutical Co, Ltd and Yakult Honsha Co, Ltd. Hironaga Satake received lecture fees from Chugai, Takeda, and Merck Biopharma. All other authors have declared no conflicts of interest.